Patents by Inventor Tsuneyuki Yamamoto

Tsuneyuki Yamamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic agent for substance dependence
    Patent number: 8318799
    Abstract: The present invention provides a therapeutic agent for substance dependence, which prevents relapse/recurrence of compulsive substance-taking behavior based on craving for addictive substances such as stimulant substances, opioids, barbiturate type anesthetics, hallucinogens, cocaine, hemp, cannabis, alcohol, or volatile organic solvents. (?)-1-(Benzofuran-2-yl)-2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof is useful as a therapeutic agent for substance dependence, which prevents relapse/recurrence of compulsive substance-taking behavior associated with craving for addictive substances.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: November 27, 2012
    Assignees: National University Corporation Kyushu University, Fujimoto Co., Ltd.
    Inventors: Tsuneyuki Yamamoto, Fumio Yoneda, Kazuhiko Morimoto
  • THERAPEUTIC AGENT FOR SUBSTANCE DEPENDENCE
    Publication number: 20100298426
    Abstract: The present invention provides a therapeutic agent for substance dependence, which prevents relapse/recurrence of compulsive substance-taking behavior based on craving for addictive substances such as stimulant substances, opioids, barbiturate type anesthetics, hallucinogens, cocaine, hemp, cannabis, alcohol, or volatile organic solvents. (?)-1-(Benzofuran-2-yl)-2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof is useful as a therapeutic agent for substance dependence, which prevents relapse/recurrence of compulsive substance-taking behavior associated with craving for addictive substances.
    Type: Application
    Filed: August 5, 2010
    Publication date: November 25, 2010
    Inventors: Tsuneyuki YAMAMOTO, Fumio Yoneda, Kazuhiko Morimoto
  • Therapeutic agent for substance dependence
    Patent number: 7825158
    Abstract: The present invention provides a therapeutic agent for substance dependence, which prevents relapse/recurrence of compulsive substance-taking behavior based on craving for addictive substances such as stimulant substances, opioids, barbiturate type anesthetics, hallucinogens, cocaine, hemp, cannabis, alcohol, or volatile organic solvents. (?)-1-(Benzofuran-2-yl)-2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof is useful as a therapeutic agent for substance dependence, which prevents relapse/recurrence of compulsive substance-taking behavior associated with craving for addictive substances.
    Type: Grant
    Filed: November 21, 2005
    Date of Patent: November 2, 2010
    Assignees: National University Corporation Kyushu University, Fujimoto Co., Ltd.
    Inventors: Tsuneyuki Yamamoto, Fumio Yoneda, Kazuhiko Morimoto
  • Therapeutic Agent for Substance Dependence
    Publication number: 20080004337
    Abstract: The present invention provides a therapeutic agent for substance dependence, which prevents relapse/recurrence of compulsive substance-taking behavior based on craving for addictive substances such as stimulant substances, opioids, barbiturate type anesthetics, hallucinogens, cocaine, hemp, cannabis, alcohol, or volatile organic solvents. (?)-1-(Benzofuran-2-yl)-2-propylaminopentane or a pharmacologically acceptable acid addition salt thereof is useful as a therapeutic agent for substance dependence, which prevents relapse/recurrence of compulsive substance-taking behavior associated with craving for addictive substances.
    Type: Application
    Filed: November 21, 2005
    Publication date: January 3, 2008
    Inventors: Tsuneyuki Yamamoto, Fumio Yoneda, Kazuhiko Morimoto
  • Anti-dementia drug
    Patent number: 5059612
    Abstract: The invention relates to a method of treating dementia, such as cerebro-vascular dementia, for example, multiple infarct dementia and amyloid angiopathic dementia, cerebro-parenchymatous dementia, such as Alzheimer's dementia and Pick's disease, and dementia caused by brain tumor, hydrocephalus, hepatic meningitis, cerebral trauma, or cerebral function disorders, comprising administering rolipram.
    Type: Grant
    Filed: September 7, 1990
    Date of Patent: October 22, 1991
    Assignee: Schering Aktiengesellschaft
    Inventors: Taiichiro Imanishi, Yasuyuki Ichimaru, Aiko Sawa, Fukio Konno, Helmut Wachtel, Showa Ueki, Michihiro Fujiwara, Tsuneyuki Yamamoto